C20H18FNO4
355.4 g/mol
APIDanger
Vidofludimus
CAS717824-30-1
Category
API
Compound Class
Amide
Primary Use
Pharmaceutical Raw Material
Vidofludimus is an orally administered small-molecule compound under investigation as an active pharmaceutical ingredient. It acts as a Nurr1 activator and DHODH inhibitor, and its calcium salt is being studied for chronic inflammatory and autoimmune conditions.
research compound for multiple sclerosis studiesresearch compound for ulcerative colitis studiesnuclear receptor-related 1 (Nurr1) activator and dihydroorotate dehydrogenase (DHODH) inhibitor for research
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 717824-30-1
Related Compounds
ReferenceSame Category
N-chloromethyl olanzapine chloride
CAS719300-59-1
pharmaceutical raw material
ReferenceSame Category
Dihydroartemisinin
CAS71939-50-9
pharmaceutical raw material
ReferenceSame Category
Α-artemether
CAS71939-51-0
pharmaceutical raw material
ReferenceSame Category
Artemether
CAS71963-77-4
pharmaceutical raw material
Referencestereoisomer of
Vidofludimus-calcium
CAS1354012-90-0
pharmaceutical raw material
Safety Reference
Danger
H302Harmful if swallowed
H360May damage fertility or the unborn child
H413May cause long lasting harmful effects to aquatic life
Identifiers
IUPAC Name
2-[[2-fluoro-4-(3-methoxyphenyl)phenyl]carbamoyl]cyclopentene-1-carboxylic acid
InChIKey
XPRDUGXOWVXZLL-UHFFFAOYSA-N
SMILES
COC1=CC=CC(=C1)C2=CC(=C(C=C2)NC(=O)C3=C(CCC3)C(=O)O)F
Synonyms (15)
- Vidofludimus (USAN/INN)
- 4sc-101;SC12267
- Vidofludimus
- vidofludimusum